Posted on January 5, 2009 by Sitemaster
There has been a lot of media noise in the past few days about two studies suggesting that a drug called alendronate (Fosamax/Merck) may be associated with a significant risk for osteonecrosis of the jaw (ONJ). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: alendronate, bisphosphonate, Fosamax, ONJ, osteonecrosis | Leave a comment »
Posted on November 8, 2008 by Sitemaster
This weekend’s prostate cancer news includes information about:
- The evolving role of 3.0 T and 1.5 T endorectal MRI in prostate cancer diagnosis
- The role of bone scans in diagnosis of men with PSA levels below and above 20 ng/ml
- A potential radio-sensitizer that may improve outcomes following radiotherapy
- A side effect of abiraterone acetate, and its management
- Bisphosphonate therapy and osteonecrosis of the jaw or ONJ … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, bisphosphonates, bone scan, endorectal MRI, jaw, ONJ, osteonecrosis | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 